Literature DB >> 19692624

Clinical evaluation of a (1,3)-beta-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients.

Valerio Del Bono1, Alessandra Mularoni, Elisa Furfaro, Emanuele Delfino, Lorenzo Rosasco, Franca Miletich, Claudio Viscoli.   

Abstract

(1,3)-beta-d-Glucan (BG) is a component of the Pneumocystis jiroveci cell wall. Thirty-one immunocompromised patients with pneumonia (16 with presumptive pneumocystis pneumonia [PCP] and 15 with non-PCP) were evaluated for serum BG levels. Serum from all 16 presumptive PCP patients and from 2/15 patients with non-PCP was positive for BG. Results indicate that BG is a reliable marker for diagnosing PCP.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19692624      PMCID： PMC2756857          DOI： 10.1128/CVI.00276-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  15 in total

Review 1.  Pneumocystis pneumonia.

Authors:  Charles F Thomas; Andrew H Limper
Journal:  N Engl J Med       Date:  2004-06-10       Impact factor: 91.245

2.  (1->3)beta-D-glucan assay positivity in patients with Pneumocystis (carinii) jiroveci pneumonia.

Authors:  Francisco M Marty; Sophia Koo; Julie Bryar; Lindsey R Baden
Journal:  Ann Intern Med       Date:  2007-07-03       Impact factor: 25.391

3.  Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.

Authors:  Luis Ostrosky-Zeichner; Barbara D Alexander; Daniel H Kett; Jose Vazquez; Peter G Pappas; Fumihiro Saeki; Paul A Ketchum; John Wingard; Robert Schiff; Hiroshi Tamura; Malcolm A Finkelman; John H Rex
Journal:  Clin Infect Dis       Date:  2005-07-21       Impact factor: 9.079

4.  Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.

Authors:  Jerry W Pickering; Howard W Sant; Catherine A P Bowles; William L Roberts; Gail L Woods
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

5.  Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.

Authors:  Carmen Pazos; José Pontón; Amalia Del Palacio
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

6.  Reactivity of (1-->3)-beta-d-glucan assay with commonly used intravenous antimicrobials.

Authors:  Francisco M Marty; Colleen M Lowry; Steven J Lempitski; David W Kubiak; Malcolm A Finkelman; Lindsey R Baden
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

7.  Detection of Pneumocystis jirovecii by two staining methods and two quantitative PCR assays.

Authors:  P Rohner; V Jacomo; R Studer; J Schrenzel; J-D Graf
Journal:  Infection       Date:  2008-12-05       Impact factor: 3.553

8.  Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.

Authors:  Zekaver Odabasi; Gloria Mattiuzzi; Elihu Estey; Hagop Kantarjian; Fumihiro Saeki; Richard J Ridge; Paul A Ketchum; Malcolm A Finkelman; John H Rex; Luis Ostrosky-Zeichner
Journal:  Clin Infect Dis       Date:  2004-06-28       Impact factor: 9.079

9.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1992-12-18

10.  1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.

Authors:  Laurence Senn; James Owen Robinson; Sabine Schmidt; Marlies Knaup; Nobuo Asahi; Shinji Satomura; Shuuji Matsuura; Bertrand Duvoisin; Jacques Bille; Thierry Calandra; Oscar Marchetti
Journal:  Clin Infect Dis       Date:  2008-03-15       Impact factor: 9.079
View more
  9 in total

1.  High Levels of beta-D-glucan in immunocompromised children with proven invasive fungal disease.

Authors:  Alessandra Mularoni; Elisa Furfaro; Maura Faraci; Alessia Franceschi; Paola Mezzano; Roberto Bandettini; Claudio Viscoli; Elio Castagnola
Journal:  Clin Vaccine Immunol       Date:  2010-03-24

2.  Serum (1->3)-{beta}-D-Glucan assay for the diagnosis of Pneumocystis jiroveci pneumonia.

Authors:  Amalia Del Palacio; Maria Soledad Cuétara; Jara Llenas-García; Maria Elena Alvarez; Fernando Chaves; Federico Pulido; Mercedes Catalán; José Pontón; Valerio Del Bono; Claudio Viscoli
Journal:  Clin Vaccine Immunol       Date:  2010-01

3.  Elevated serum beta-D-glucan levels in immunocompromised children with clinical suspicion for Pneumocystis jirovecii pneumonia.

Authors:  Blanca E Gonzalez; Luis A Faverio; Francisco M Marty; Craig MacArthur; Robin B Churchill
Journal:  Clin Vaccine Immunol       Date:  2011-05-04

4.  Thymopoietic and bone marrow response to murine Pneumocystis pneumonia.

Authors:  Xin Shi; Ping Zhang; Gregory D Sempowski; Judd E Shellito
Journal:  Infect Immun       Date:  2011-02-22       Impact factor: 3.441

5.  Serum (1->3)-beta-D-glucan levels in primary infection and pulmonary colonization with Pneumocystis jirovecii.

Authors:  Céline Damiani; Solène Le Gal; Delphine Lejeune; Naima Brahimi; Michèle Virmaux; Gilles Nevez; Anne Totet
Journal:  J Clin Microbiol       Date:  2011-03-23       Impact factor: 5.948

6.  Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections.

Authors:  Valerio Del Bono; Emanuele Delfino; Elisa Furfaro; Malgorzata Mikulska; Elena Nicco; Paolo Bruzzi; Alessandra Mularoni; Matteo Bassetti; Claudio Viscoli
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

7.  Pneumocystis pneumonia during Postoperative Adjuvant Chemotherapy for Breast Cancer.

Authors:  Tsuyoshi Shinohara; Makito Yasui; Hiroyuki Yamada; Yoshiro Fujimori; Kiyofumi Yamagishi
Journal:  Case Rep Oncol Med       Date:  2013-05-16

8.  Pneumocystis jirovecii Pneumonia in Patients with Nephrotic Syndrome: Application of Lymphocyte Subset Analysis in Predicting Clinical Outcomes.

Authors:  Yang Liu; Ke Zheng; Yecheng Liu; Huadong Zhu
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-02-20       Impact factor: 2.471

Review 9.  Beta-D-Glucan in Patients with Haematological Malignancies.

Authors:  Malgorzata Mikulska; Elisa Balletto; Elio Castagnola; Alessandra Mularoni
Journal:  J Fungi (Basel)       Date:  2021-12-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.